Journal articleN Engl J Med2013
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
- Journal
- N Engl J Med
- Published
- 16 October 2013
- Citations
- 5,132
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 26
- Its registry lists this paper as resultsPhase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma o… NCT00844649↗
- BackgroundNALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer NCT07595172↗
- BackgroundStereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and … NCT07173374↗
- BackgroundSystemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer NCT04276857↗
- BackgroundOnvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer NCT06736717↗
- BackgroundPancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX NCT06349278↗
- BackgroundSintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer NCT06050317↗
- BackgroundPancreatic Cancer Detection Consortium NCT06388967↗
- BackgroundEfficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients NCT05065801↗
- BackgroundThe First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients NCT05168527↗
- BackgroundExploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With … NCT04787991↗
- BackgroundSurvival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry… NCT04984174↗
- BackgroundPharmacotyping of Pancreatic Patient-derived Organoids NCT05196334↗
- BackgroundSequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With… NCT04570943↗
- BackgroundTAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma NCT04923529↗
- BackgroundMicrowave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis NCT04677192↗
- Background1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma NCT04098081↗
- BackgroundStudy of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas NCT03779464↗
- BackgroundA Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX NCT03450018↗
- BackgroundEvaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma NCT03717298↗
- BackgroundEfficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer NCT03502343↗
- BackgroundTrial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma NCT03077685↗
- BackgroundSafety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previousl… NCT03214250↗
- BackgroundProspectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis NCT02869802↗
- BackgroundA Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. NCT02021500↗
- BackgroundPancreatic Surgery in Elderly Patients NCT04893408↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.